kwic
while
while
right
off
ON
170
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for while out of >500 occurrences
341393 occurrences (No.55 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to while]
341393 occurrences (No.55 in the rank) during 5 years in the PubMed. [cache]
| 170) Most part of studies concerned non-small-cell-LC patients (29 out of 32) while none focused on small-cell-LC. |
| PMID:34300130 DOI:10.3390/ijerph18147679 |
| 2021 International journal of environmental research and public health |
| * Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data. |
| - Routinely collected electronic healthcare data (rcEHD) have a tremendous potential for enriching pre-marketing evidence on target- and immunotherapies used to treat lung cancer (LC). A scoping review was performed to provide a structured overview of available rcEHD-based studies on this topic and to support the execution of future research by facilitating access to pertinent literature both for study design and benchmarking. Eligible studies published between 2016 and 2020 in PubMed and ISI Web of Science were searched. Data source and study characteristics, as well as evidence on drug utilization and survival were extracted. Thirty-two studies were included. Twenty-six studies used North American data, while three used European data only. Thirteen studies linked ≥1 data source types among administrative/claims data, cancer registries and medical/health records. Twenty-nine studies retrieved cancer-related information from medical records/cancer registries and 31 studies retrieved information on drug utilization or survival from medical records or administrative/claim data. Most part of studies concerned non-small-cell-LC patients (29 out of 32) while none focused on small-cell-LC. Study cohorts ranged between 85 to 81,983 patients. Only two studies described first-line utilization of immunotherapies. Results from this review will serve as a starting point for the execution of future rcEHD-based studies on innovative LC pharmacotherapies. |
[
right
kwic]
(1)64  the |
(14)4 others |
(27)2 aged |
(40)2 minimizing |
| (2)11 also |
(15)4 several |
(28)2 asthma |
(41)2 on |
| (3)10 there |
(16)4 simultaneously |
(29)2 being |
(42)2 preserving |
| (4)9 a |
(17)4 social |
(30)2 both |
(43)2 previous |
| (5)7 in |
(18)3 avoiding |
(31)2 clinical |
(44)2 reducing |
| (6)7 most |
(19)3 many |
(32)2 commercial |
(45)2 screening |
| (7)7 some |
(20)3 more |
(33)2 controlling |
(46)2 showing |
| (8)7 these |
(21)3 none |
(34)2 identifying |
(47)2 syphilis |
| (9)6 it |
(22)3 promoting |
(35)2 improving |
(48)2 three |
| (10)4 all |
(23)3 this |
(36)2 intrusive |
(49)2 two |
| (11)4 for |
(24)3 using |
(37)2 its |
(50)2 walking |
| (12)4 maintaining |
(25)2 N |
(38)2 living |
|
| (13)4 no |
(26)2 accounting |
(39)2 longer |
add keyword
--- WordNet output for while ---